1-7 of 7
Shaomei Feng
Close
Sort by
Journal Articles

Assessment of Activities of Daily Living (ADL)Scale Can be Used to Predict Overall Survival after CAR-T Cell Therapy in Elderly Patient(over 70 years of age) with Refractory/Relapsed B-Cell Lymphoma

Fan Yang, Rui Liu, Teng Xu, Zhonghua Fu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui SHI, Lixia Ma, Guoai Su, Biping Deng, Xiaoyan Ke, Kai HU
Journal: Blood
Blood (2023) 142 (Supplement 1): 6922.
https://doi.org/10.1182/blood-2023-177836
Published: 2023
Journal Articles

A Compilation of Experiences in Utilizing CAR-T Cell Therapy for Richter's Transformation

Shaomei Feng, Teng Xu, Haidi Liu, Peihao Zheng, Lixia Ma, Hui SHI, Tong Wu, Fan Yang, Kai HU, Xiaoyan Ke
Journal: Blood
Blood (2023) 142 (Supplement 1): 4638.
https://doi.org/10.1182/blood-2023-182797
Published: 2023
Journal Articles

Evaluating the Impact of Cryopreservation of PBMCs on CAR-T Therapy Efficacy and Safety in DLBCL Patients: An Informative Approach to Optimize Manufacturing Strategies

Teng Xu, Fan Yang, Rui Liu, Zhonghua Fu, Na Li, Xiaoyan Ke, Shaomei Feng, Biping Deng, Kai Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3513.
https://doi.org/10.1182/blood-2023-185590
Published: 2023
Journal Articles

Exploring the Efficiency and Survival of CAR T-Cell Therapy in DLBCL Patients with MYC and/or TP53 Abnormalities

Peihao Zheng, Rui Liu, Teng Xu, Fan Yang, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui Shi, Hongwei Yu, Biping Deng, Xiaoyan Ke, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7548–7549.
https://doi.org/10.1182/blood-2022-168018
Published: 2022
Journal Articles

Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy

Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Lixia Ma, Hui SHI, Biping Deng, Xiaoyan Ke, Tong Wu, Kai Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10384–10385.
https://doi.org/10.1182/blood-2022-164446
Published: 2022
Journal Articles

Safety and Short-Term Efficacy of CART Cells in Treatment of Diffuse Large B-Cell Lymphoma with Follicular Transformation

Kai Hu, Shaomei Feng
Journal: Blood
Blood (2021) 138 (Supplement 1): 4845.
https://doi.org/10.1182/blood-2021-154459
Published: 2021
Journal Articles

Auto Hematopoietic Stem Cell Transplantation Combined with Another Target Humanized CAR-T Cells for Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Failure of Murinized CD19-CAR-T Therapy

Kai Hu, Fan Yang, Rui Liu, Teng Xu, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui Shi, Biping Deng, Xiaoyan Ke, Tong Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 657.
https://doi.org/10.1182/blood-2021-146801
Published: 2021